Unknown

Dataset Information

0

Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [11C]UCB-J PET study in a model of obsessive-compulsive disorder-like behaviour.


ABSTRACT: BACKGROUND:Currently, the evidence on synaptic abnormalities in neuropsychiatric disorders-including obsessive-compulsive disorder (OCD)-is emerging. The newly established positron emission tomography (PET) ligand ((R)-1-((3-((11)C-methyl-(11)C)pyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one) ([11C]UCB-J) provides the opportunity to visualize synaptic density changes in vivo, by targeting the synaptic vesicle protein 2A (SV2A). Here, we aim to evaluate such alterations in the brain of the SAP90/PSD-95-associated protein 3 (Sapap3) knockout (ko) mouse model, showing an abnormal corticostriatal neurotransmission resulting in OCD-like behaviour. METHODS:Longitudinal [11C]UCB-J µPET/CT scans were acquired in Sapap3 ko and wildtype (wt) control mice (n?=?9/group) to study SV2A availability. Based on the Logan reference method, we calculated the volume of distribution (VT(IDIF)) for [11C]UCB-J. Both cross-sectional (wt vs. ko) and longitudinal (3 vs. 9 months) volume-of-interest-based statistical analysis and voxel-based statistical parametric mapping were performed. Both [11C]UCB-J ex vivo autoradiography and [3H]UCB-J in vitro autoradiography were used for the validation of the µPET data. RESULTS:At the age of 3 months, Sapap3 ko mice are already characterized by a significantly lower SV2A availability compared to wt littermates (i.a. cortex - 12.69%, p?

SUBMITTER: Glorie D 

PROVIDER: S-EPMC7666267 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [<sup>11</sup>C]UCB-J PET study in a model of obsessive-compulsive disorder-like behaviour.

Glorie Dorien D   Verhaeghe Jeroen J   Miranda Alan A   De Lombaerde Stef S   Stroobants Sigrid S   Staelens Steven S  

EJNMMI research 20201113 1


<h4>Background</h4>Currently, the evidence on synaptic abnormalities in neuropsychiatric disorders-including obsessive-compulsive disorder (OCD)-is emerging. The newly established positron emission tomography (PET) ligand ((R)-1-((3-((11)C-methyl-(11)C)pyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one) ([<sup>11</sup>C]UCB-J) provides the opportunity to visualize synaptic density changes in vivo, by targeting the synaptic vesicle protein 2A (SV2A). Here, we aim to evaluate such alte  ...[more]

Similar Datasets

| S-EPMC7752786 | biostudies-literature
| S-EPMC8283163 | biostudies-literature
| S-EPMC8452380 | biostudies-literature
| S-EPMC3687030 | biostudies-literature
| S-EPMC8065069 | biostudies-literature
| S-EPMC9065222 | biostudies-literature
| S-EPMC9381645 | biostudies-literature
| S-EPMC9122519 | biostudies-literature
| S-EPMC7786921 | biostudies-literature
| S-EPMC7611123 | biostudies-literature